IV Dosing, BSA-Based

Loading...

sq.m

References

  1. Jennifer J Griggs. Appropriate Systemic Therapy Dosing for Obese Adult Patients With Cancer: ASCO Guideline Update.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2021
  2. G. Dhall. DDEL-02. DECREASED TOXICITY OF CONVENTIONAL DOSE CHEMOTHERAPY UTILIZING BODY WEIGHT INSTEAD OF BODY SURFACE AREA FOR DOSING IN YOUNG CHILDREN <6 YEARS OLD ENROLLED ON THE “HEAD START” 4 CLINICAL TRIAL. Neuro-Oncology, 2020
  3. S. Krens. Dose recommendations for anticancer drugs in patients with renal or hepatic impairment.. The Lancet. Oncology, 2019
  4. G. Dhall. PHRM-05. INCREASED TOXICITY OF CONVENTIONAL DOSE CHEMOTHERAPY UTILIZING BODY SURFACE AREA FOR DOSING IN INFANTS AND YOUNG CHILDREN ENROLLED ON THE “HEAD START” 4 CLINICAL TRIAL. Neuro-Oncology, 2018
  5. Mirjam N Trame. Population Pharmacokinetics of Busulfan in Children: Increased Evidence for Body Surface Area and Allometric Body Weight Dosing of Busulfan in Children. Clinical Cancer Research, 2011
  6. S. Baker. Role of body surface area in dosing of investigational anticancer agents in adults, 1991-2001.. Journal of the National Cancer Institute, 2002
  7. F. E. Jongh. Body-surface area-based dosing does not increase accuracy of predicting cisplatin exposure.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001
  8. H. Gurney. Dose calculation of anticancer drugs: a review of the current practice and introduction of an alternative.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1996